254 related articles for article (PubMed ID: 31447009)
1. Palliative thoracic radiotherapy near the end of life in lung cancer: A population-based analysis.
Fraser I; Lefresne S; Regan J; Berthelet E; Chooback N; Ho C; Olson R
Lung Cancer; 2019 Sep; 135():97-103. PubMed ID: 31447009
[TBL] [Abstract][Full Text] [Related]
2. Utilization of palliative radiotherapy for bone metastases near end of life in a population-based cohort.
Tiwana MS; Barnes M; Kiraly A; Olson RA
BMC Palliat Care; 2016 Jan; 15():2. PubMed ID: 26748495
[TBL] [Abstract][Full Text] [Related]
3. Has the pattern of practice in the prescription of radiotherapy for the palliation of thoracic symptoms changed between 1999 and 2006 at the rapid response radiotherapy program?
Fairchild A; Goh P; Sinclair E; Barnes EA; Ghosh S; Danjoux C; Barbera L; Tsao M; Chow E
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):693-700. PubMed ID: 18262087
[TBL] [Abstract][Full Text] [Related]
4. Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy?
Sundstrøm S; Bremnes RM; Brunsvig P; Aasebø U; Kaasa S;
J Thorac Oncol; 2006 Oct; 1(8):816-24. PubMed ID: 17409965
[TBL] [Abstract][Full Text] [Related]
5. Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study.
Chen AB; Cronin A; Weeks JC; Chrischilles EA; Malin J; Hayman JA; Schrag D
J Clin Oncol; 2013 Feb; 31(5):558-64. PubMed ID: 23295799
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
7. Palliative thoracic radiotherapy in advanced lung cancer: A single institution experience.
Hotwani C; Agarwal JP; Prabhash K; Munshi A; Joshi A; Misra S; Kumar D; Das S; Laskar SG
Indian J Cancer; 2017; 54(1):262-266. PubMed ID: 29199702
[TBL] [Abstract][Full Text] [Related]
8. Radiation therapy at the end of life in patients with incurable nonsmall cell lung cancer.
Kapadia NS; Mamet R; Zornosa C; Niland JC; D'Amico TA; Hayman JA
Cancer; 2012 Sep; 118(17):4339-45. PubMed ID: 22252390
[TBL] [Abstract][Full Text] [Related]
9. The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases.
Chiang Y; Yang JC; Hsu FM; Chen YH; Shih JY; Lin ZZ; Lan KH; Cheng AL; Kuo SH
PLoS One; 2015; 10(12):e0145936. PubMed ID: 26720170
[TBL] [Abstract][Full Text] [Related]
10. How Should Palliative Thoracic Radiotherapy Be Fractionated for Octogenarians with Lung Cancer?
Nieder C; Yobuta R; Mannsåker B; Dalhaug A
In Vivo; 2018; 32(2):331-336. PubMed ID: 29475917
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerance of thoracic radiotherapy in the oldest old patients: A case series.
Mery B; Rancoule C; Assouline A; Aissou L; Falk AT; Auberdiac P; Vallard A; Chargari C; Magné N
Indian J Cancer; 2019; 56(2):163-166. PubMed ID: 31062737
[TBL] [Abstract][Full Text] [Related]
12. Palliative thoracic radiotherapy for patients with advanced non-small cell lung cancer and poor performance status.
Walasek T; Sas-Korczyńska B; Dąbrowski T; Reinfuss M; Jakubowicz J; Blecharz P; Łuczyńska E; Darasz Z; Skotnicki P
Lung Cancer; 2015 Feb; 87(2):130-5. PubMed ID: 25484031
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung Cancer.
Koshy M; Malik R; Mahmood U; Husain Z; Weichselbaum RR; Sher DJ
J Natl Cancer Inst; 2015 Dec; 107(12):djv278. PubMed ID: 26424779
[TBL] [Abstract][Full Text] [Related]
14. Split-course palliative radiotherapy for advanced non-small cell lung cancer.
Metcalfe SK; Milano MT; Bylund K; Smudzin T; Rubin P; Chen Y
J Thorac Oncol; 2010 Feb; 5(2):185-90. PubMed ID: 20009771
[TBL] [Abstract][Full Text] [Related]
15. End stage palliative care of head and neck cancer: a case study.
Shishodia NP; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Pathan AA; Parine NR; Chandroth SV; Purushothaman B
Asian Pac J Cancer Prev; 2015; 16(3):1255-8. PubMed ID: 25735365
[TBL] [Abstract][Full Text] [Related]
16. Palliative thoracic radiotherapy for lung cancer.
Kepka L; Olszyna-Serementa M
Expert Rev Anticancer Ther; 2010 Apr; 10(4):559-69. PubMed ID: 20397921
[TBL] [Abstract][Full Text] [Related]
17. Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial.
Falk SJ; Girling DJ; White RJ; Hopwood P; Harvey A; Qian W; Stephens RJ;
BMJ; 2002 Aug; 325(7362):465. PubMed ID: 12202326
[TBL] [Abstract][Full Text] [Related]
18. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party.
Macbeth FR; Bolger JJ; Hopwood P; Bleehen NM; Cartmell J; Girling DJ; Machin D; Stephens RJ; Bailey AJ
Clin Oncol (R Coll Radiol); 1996; 8(3):167-75. PubMed ID: 8814371
[TBL] [Abstract][Full Text] [Related]
20. Palliative Chemotherapy Near the End of Life in Oncology Patients.
Zhang Z; Chen ML; Gu XL; Liu MH; Zhao WW; Cheng WW
Am J Hosp Palliat Care; 2018 Sep; 35(9):1215-1220. PubMed ID: 29529885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
